Chang Wang

1 Qiu Yang Road
Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Cost-effectiveness analysis of inavolisib combined with palbociclib plus fulvestrant in PIK3CA-mutated HR+/Her2- advanced breast cancer in China.

Cost-effectiveness analysis of inavolisib combined with palbociclib plus fulvestrant in PIK3CA-mutated HR+/Her2- advanced breast cancer in China.

Journal: Frontiers in pharmacology

Published: November 09, 2025

Lung cancer palindromia due to the deficiency of vital energy and blood syndrome treated by TCM herbs: A case report.

Lung cancer palindromia due to the deficiency of vital energy and blood syndrome treated by TCM herbs: A case report.

Journal: Medicine

Published: April 04, 2025

Cost-effectiveness of HLX01 (Hanlikang®) vs. rituximab combined with CHOP in treatment-naive diffuse large B-Cell lymphoma: a partitioned survival model analysis.

Cost-effectiveness of HLX01 (Hanlikang®) vs. rituximab combined with CHOP in treatment-naive diffuse large B-Cell lymphoma: a partitioned survival model analysis.

Journal: Frontiers in pharmacology

Published: September 19, 2024

Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US.

Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US.

Journal: Frontiers in immunology

Published: August 16, 2024

Visualizing Phase Evolution of Co2C for Efficient Fischer-Tropsch to Olefins.

Visualizing Phase Evolution of Co2C for Efficient Fischer-Tropsch to Olefins.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: March 19, 2024

Comparative cost-effectiveness of first-line pembrolizumab plus chemotherapy vs. chemotherapy alone in persistent, recurrent, or metastatic cervical cancer.

Comparative cost-effectiveness of first-line pembrolizumab plus chemotherapy vs. chemotherapy alone in persistent, recurrent, or metastatic cervical cancer.

Journal: Frontiers in immunology

Published: November 28, 2023

Alloying Matters for Ordering: Synthesis of Highly Ordered PtCo Intermetallic Catalysts for Fuel Cells.

Alloying Matters for Ordering: Synthesis of Highly Ordered PtCo Intermetallic Catalysts for Fuel Cells.

Journal: Inorganic chemistry

Published: March 22, 2023

Phase diagrams guide synthesis of highly ordered intermetallic electrocatalysts: separating alloying and ordering stages.

Phase diagrams guide synthesis of highly ordered intermetallic electrocatalysts: separating alloying and ordering stages.

Journal: Nature communications

Published: October 01, 2022

Cost-Effectiveness of Nivolumab Immunotherapy vs. Paclitaxel or Docetaxel Chemotherapy as Second-Line Therapy in Advanced Esophageal Squamous Cell Carcinoma in China.

Cost-Effectiveness of Nivolumab Immunotherapy vs. Paclitaxel or Docetaxel Chemotherapy as Second-Line Therapy in Advanced Esophageal Squamous Cell Carcinoma in China.

Journal: Frontiers in public health

Published: May 04, 2022

Effects of exercise interventions on cancer-related fatigue in breast cancer patients: an overview of systematic reviews.

Effects of exercise interventions on cancer-related fatigue in breast cancer patients: an overview of systematic reviews.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: February 21, 2022

Latent Epstein-Barr virus infection status and prognosis in patients with newly diagnosed Hodgkin lymphoma in Southeast China: a single-center retrospective study.

Latent Epstein-Barr virus infection status and prognosis in patients with newly diagnosed Hodgkin lymphoma in Southeast China: a single-center retrospective study.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 08, 2021

Analysis of the Predictive Value of EZH2 Expression Level on the Clinical Efficacy and Long-term Prognosis of Patients with Primary Gastrointestinal Diffuse Large B-cell Lymphoma

Analysis of the Predictive Value of EZH2 Expression Level on the Clinical Efficacy and Long-term Prognosis of Patients with Primary Gastrointestinal Diffuse Large B-cell Lymphoma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 09, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026